4BIO Capital backs Estuary Biotherapeutics' USD 93 million Series A
Estuary Biotherapeutics raised USD 93 million in Series A financing led by RA Capital Management, with participation from 4BIO Capital and GV. The financing brings total funding to USD 103 million, including a USD 10 million seed round co-led by the two returning investors. Estuary develops locally delivered gene thera